HEADER SIGNALING PROTEIN 13-JUN-13 4L7E TITLE THREE DIMENSIONAL STRUCTURE OF MUTANT D78A OF HUMAN HD DOMAIN- TITLE 2 CONTAINING PROTEIN 2, GENOMICS CONSORTIUM (NESG) TARGET HR6723 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HD DOMAIN-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HEPATITIS C VIRUS NS5A-TRANSACTIVATED PROTEIN 2, HCV NS5A- COMPND 5 TRANSACTIVATED PROTEIN 2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HDDC2, C6ORF74, NS5ATP2, CGI-130; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15_NESG KEYWDS STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, KEYWDS 2 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, HDCC2 MUTANT D78A, KEYWDS 3 SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.KUZIN,M.SU,A.YAKUNIN,N.BELOGLAZOVA,J.SEETHARAMAN,M.MAGLAQUI,R.XIAO, AUTHOR 2 D.LEE,G.BROWN,R.FLICK,J.K.EVERETT,T.B.ACTON,G.T.MONTELIONE,J.F.HUNT, AUTHOR 3 L.TONG,NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 4 06-DEC-23 4L7E 1 REMARK REVDAT 3 20-SEP-23 4L7E 1 REMARK LINK REVDAT 2 24-JAN-18 4L7E 1 AUTHOR JRNL REVDAT 1 24-JUL-13 4L7E 0 JRNL AUTH A.KUZIN,M.SU,A.YAKUNIN,N.BELOGLAZOVA,J.SEETHARAMAN, JRNL AUTH 2 M.MAGLAQUI,R.XIAO,D.LEE,G.BROWN,R.FLICK,J.K.EVERETT, JRNL AUTH 3 T.B.ACTON,G.T.MONTELIONE,J.F.HUNT,L.TONG, JRNL AUTH 4 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) JRNL TITL NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR6723 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.23 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_1269 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.23 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.57 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.440 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 24153 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.176 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1221 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.5776 - 4.6343 1.00 2695 148 0.1818 0.2098 REMARK 3 2 4.6343 - 3.6789 1.00 2594 139 0.1524 0.1919 REMARK 3 3 3.6789 - 3.2139 1.00 2564 135 0.1740 0.2121 REMARK 3 4 3.2139 - 2.9201 1.00 2548 128 0.1830 0.2344 REMARK 3 5 2.9201 - 2.7109 1.00 2529 142 0.1648 0.2246 REMARK 3 6 2.7109 - 2.5510 1.00 2508 131 0.1543 0.1966 REMARK 3 7 2.5510 - 2.4233 1.00 2525 127 0.1682 0.2238 REMARK 3 8 2.4233 - 2.3178 1.00 2501 141 0.1825 0.2008 REMARK 3 9 2.3178 - 2.2286 0.99 2468 130 0.2453 0.3253 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.240 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.15 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3196 REMARK 3 ANGLE : 1.077 4286 REMARK 3 CHIRALITY : 0.064 459 REMARK 3 PLANARITY : 0.004 561 REMARK 3 DIHEDRAL : 14.388 1258 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 20.0149 12.5146 15.5944 REMARK 3 T TENSOR REMARK 3 T11: 0.2314 T22: 0.2320 REMARK 3 T33: 0.2064 T12: -0.0359 REMARK 3 T13: -0.0110 T23: 0.0146 REMARK 3 L TENSOR REMARK 3 L11: 1.3846 L22: 0.8380 REMARK 3 L33: 1.1613 L12: -0.3682 REMARK 3 L13: 0.1704 L23: -0.1629 REMARK 3 S TENSOR REMARK 3 S11: 0.0186 S12: 0.0037 S13: -0.0574 REMARK 3 S21: 0.0326 S22: -0.0626 S23: 0.0405 REMARK 3 S31: 0.0113 S32: -0.1616 S33: 0.0471 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4L7E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-JUN-13. REMARK 100 THE DEPOSITION ID IS D_1000080274. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24213 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : 0.09200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BALBES REMARK 200 STARTING MODEL: PDB ENTRY 4DMB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN SOLUTION: 100MM NACL, 5MM DTT, REMARK 280 0.02% NAN3, 10MM TRIS-HCL (PH 7.5) . RESERVOIR SOLUTION:0.1M REMARK 280 LICL, 0.1M SODIUM ACETATE, 40% PEG1000, MICROBATCH UNDER OIL, REMARK 280 TEMPERATURE 277K, PH 5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.88100 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.07700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.44300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.07700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.88100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.44300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMER,44.42 KD,92.5% REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 VAL A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 ALA A 7 REMARK 465 THR A 8 REMARK 465 PHE A 9 REMARK 465 SEP A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 199 REMARK 465 SER A 200 REMARK 465 GLU A 201 REMARK 465 PRO A 202 REMARK 465 HIS A 203 REMARK 465 SER A 204 REMARK 465 MSE B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 VAL B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 ALA B 199 REMARK 465 SER B 200 REMARK 465 GLU B 201 REMARK 465 PRO B 202 REMARK 465 HIS B 203 REMARK 465 SER B 204 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 62 105.27 -170.37 REMARK 500 LEU A 164 33.20 -96.69 REMARK 500 ASN A 176 -16.43 -146.45 REMARK 500 ASP B 62 103.97 -163.30 REMARK 500 LEU B 164 30.21 -96.12 REMARK 500 ASN B 176 -11.06 -142.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 PEG B 306 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 306 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4DMB RELATED DB: PDB REMARK 900 D78A MUTANT REMARK 900 RELATED ID: NESG-HR6723 RELATED DB: TARGETTRACK DBREF 4L7E A 1 204 UNP Q7Z4H3 HDDC2_HUMAN 1 204 DBREF 4L7E B 1 204 UNP Q7Z4H3 HDDC2_HUMAN 1 204 SEQADV 4L7E ALA A 78 UNP Q7Z4H3 ASP 78 ENGINEERED MUTATION SEQADV 4L7E ALA B 78 UNP Q7Z4H3 ASP 78 ENGINEERED MUTATION SEQRES 1 A 204 MSE ALA SER VAL SER SER ALA THR PHE SEP GLY HIS GLY SEQRES 2 A 204 ALA ARG SER LEU LEU GLN PHE LEU ARG LEU VAL GLY GLN SEQRES 3 A 204 LEU LYS ARG VAL PRO ARG THR GLY TRP VAL TYR ARG ASN SEQRES 4 A 204 VAL GLN ARG PRO GLU SER VAL SER ASP HIS MSE TYR ARG SEQRES 5 A 204 MSE ALA VAL MSE ALA MSE VAL ILE LYS ASP ASP ARG LEU SEQRES 6 A 204 ASN LYS ASP ARG CYS VAL ARG LEU ALA LEU VAL HIS ALA SEQRES 7 A 204 MSE ALA GLU CYS ILE VAL GLY ASP ILE ALA PRO ALA ASP SEQRES 8 A 204 ASN ILE PRO LYS GLU GLU LYS HIS ARG ARG GLU GLU GLU SEQRES 9 A 204 ALA MSE LYS GLN ILE THR GLN LEU LEU PRO GLU ASP LEU SEQRES 10 A 204 ARG LYS GLU LEU TYR GLU LEU TRP GLU GLU TYR GLU THR SEQRES 11 A 204 GLN SER SER ALA GLU ALA LYS PHE VAL LYS GLN LEU ASP SEQRES 12 A 204 GLN CYS GLU MSE ILE LEU GLN ALA SER GLU TYR GLU ASP SEQRES 13 A 204 LEU GLU HIS LYS PRO GLY ARG LEU GLN ASP PHE TYR ASP SEQRES 14 A 204 SER THR ALA GLY LYS PHE ASN HIS PRO GLU ILE VAL GLN SEQRES 15 A 204 LEU VAL SER GLU LEU GLU ALA GLU ARG SER THR ASN ILE SEQRES 16 A 204 ALA ALA ALA ALA SER GLU PRO HIS SER SEQRES 1 B 204 MSE ALA SER VAL SER SER ALA THR PHE SEP GLY HIS GLY SEQRES 2 B 204 ALA ARG SER LEU LEU GLN PHE LEU ARG LEU VAL GLY GLN SEQRES 3 B 204 LEU LYS ARG VAL PRO ARG THR GLY TRP VAL TYR ARG ASN SEQRES 4 B 204 VAL GLN ARG PRO GLU SER VAL SER ASP HIS MSE TYR ARG SEQRES 5 B 204 MSE ALA VAL MSE ALA MSE VAL ILE LYS ASP ASP ARG LEU SEQRES 6 B 204 ASN LYS ASP ARG CYS VAL ARG LEU ALA LEU VAL HIS ALA SEQRES 7 B 204 MSE ALA GLU CYS ILE VAL GLY ASP ILE ALA PRO ALA ASP SEQRES 8 B 204 ASN ILE PRO LYS GLU GLU LYS HIS ARG ARG GLU GLU GLU SEQRES 9 B 204 ALA MSE LYS GLN ILE THR GLN LEU LEU PRO GLU ASP LEU SEQRES 10 B 204 ARG LYS GLU LEU TYR GLU LEU TRP GLU GLU TYR GLU THR SEQRES 11 B 204 GLN SER SER ALA GLU ALA LYS PHE VAL LYS GLN LEU ASP SEQRES 12 B 204 GLN CYS GLU MSE ILE LEU GLN ALA SER GLU TYR GLU ASP SEQRES 13 B 204 LEU GLU HIS LYS PRO GLY ARG LEU GLN ASP PHE TYR ASP SEQRES 14 B 204 SER THR ALA GLY LYS PHE ASN HIS PRO GLU ILE VAL GLN SEQRES 15 B 204 LEU VAL SER GLU LEU GLU ALA GLU ARG SER THR ASN ILE SEQRES 16 B 204 ALA ALA ALA ALA SER GLU PRO HIS SER MODRES 4L7E MSE A 50 MET SELENOMETHIONINE MODRES 4L7E MSE A 53 MET SELENOMETHIONINE MODRES 4L7E MSE A 56 MET SELENOMETHIONINE MODRES 4L7E MSE A 58 MET SELENOMETHIONINE MODRES 4L7E MSE A 79 MET SELENOMETHIONINE MODRES 4L7E MSE A 106 MET SELENOMETHIONINE MODRES 4L7E MSE A 147 MET SELENOMETHIONINE MODRES 4L7E SEP B 10 SER PHOSPHOSERINE MODRES 4L7E MSE B 50 MET SELENOMETHIONINE MODRES 4L7E MSE B 53 MET SELENOMETHIONINE MODRES 4L7E MSE B 56 MET SELENOMETHIONINE MODRES 4L7E MSE B 58 MET SELENOMETHIONINE MODRES 4L7E MSE B 79 MET SELENOMETHIONINE MODRES 4L7E MSE B 106 MET SELENOMETHIONINE MODRES 4L7E MSE B 147 MET SELENOMETHIONINE HET MSE A 50 8 HET MSE A 53 8 HET MSE A 56 8 HET MSE A 58 8 HET MSE A 79 8 HET MSE A 106 8 HET MSE A 147 8 HET SEP B 10 10 HET MSE B 50 8 HET MSE B 53 8 HET MSE B 56 8 HET MSE B 58 8 HET MSE B 79 8 HET MSE B 106 8 HET MSE B 147 8 HET CL A 301 1 HET PEG A 302 7 HET PEG A 303 7 HET PEG A 304 7 HET PEG A 305 7 HET UNL A 306 3 HET CL B 301 1 HET PEG B 302 7 HET PEG B 303 7 HET UNL B 304 3 HET PEG B 305 7 HET PEG B 306 4 HETNAM MSE SELENOMETHIONINE HETNAM SEP PHOSPHOSERINE HETNAM CL CHLORIDE ION HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM UNL UNKNOWN LIGAND HETSYN SEP PHOSPHONOSERINE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 2 SEP C3 H8 N O6 P FORMUL 3 CL 2(CL 1-) FORMUL 4 PEG 8(C4 H10 O3) FORMUL 15 HOH *102(H2 O) HELIX 1 1 GLY A 13 LEU A 27 1 15 HELIX 2 2 LYS A 28 VAL A 30 5 3 HELIX 3 3 ARG A 32 ARG A 38 1 7 HELIX 4 4 SER A 45 ILE A 60 1 16 HELIX 5 5 ASN A 66 HIS A 77 1 12 HELIX 6 6 ALA A 80 GLY A 85 1 6 HELIX 7 7 ALA A 88 ASN A 92 5 5 HELIX 8 8 PRO A 94 GLN A 111 1 18 HELIX 9 9 PRO A 114 THR A 130 1 17 HELIX 10 10 SER A 133 HIS A 159 1 27 HELIX 11 11 LEU A 164 SER A 170 1 7 HELIX 12 12 HIS A 177 ALA A 198 1 22 HELIX 13 13 GLY B 13 GLN B 26 1 14 HELIX 14 14 LEU B 27 VAL B 30 5 4 HELIX 15 15 ARG B 32 ARG B 38 1 7 HELIX 16 16 SER B 45 ILE B 60 1 16 HELIX 17 17 ASN B 66 HIS B 77 1 12 HELIX 18 18 ALA B 80 GLY B 85 1 6 HELIX 19 19 ALA B 88 ASN B 92 5 5 HELIX 20 20 PRO B 94 GLN B 111 1 18 HELIX 21 21 PRO B 114 THR B 130 1 17 HELIX 22 22 SER B 133 HIS B 159 1 27 HELIX 23 23 LEU B 164 SER B 170 1 7 HELIX 24 24 HIS B 177 ALA B 198 1 22 LINK C HIS A 49 N MSE A 50 1555 1555 1.33 LINK C MSE A 50 N TYR A 51 1555 1555 1.33 LINK C ARG A 52 N MSE A 53 1555 1555 1.33 LINK C MSE A 53 N ALA A 54 1555 1555 1.33 LINK C VAL A 55 N MSE A 56 1555 1555 1.33 LINK C MSE A 56 N ALA A 57 1555 1555 1.33 LINK C ALA A 57 N MSE A 58 1555 1555 1.33 LINK C MSE A 58 N VAL A 59 1555 1555 1.33 LINK C ALA A 78 N MSE A 79 1555 1555 1.33 LINK C MSE A 79 N ALA A 80 1555 1555 1.33 LINK C ALA A 105 N MSE A 106 1555 1555 1.33 LINK C MSE A 106 N LYS A 107 1555 1555 1.33 LINK C GLU A 146 N MSE A 147 1555 1555 1.32 LINK C MSE A 147 N ILE A 148 1555 1555 1.33 LINK C PHE B 9 N SEP B 10 1555 1555 1.33 LINK C SEP B 10 N GLY B 11 1555 1555 1.33 LINK C HIS B 49 N MSE B 50 1555 1555 1.33 LINK C MSE B 50 N TYR B 51 1555 1555 1.34 LINK C ARG B 52 N MSE B 53 1555 1555 1.33 LINK C MSE B 53 N ALA B 54 1555 1555 1.33 LINK C VAL B 55 N MSE B 56 1555 1555 1.33 LINK C MSE B 56 N ALA B 57 1555 1555 1.33 LINK C ALA B 57 N MSE B 58 1555 1555 1.33 LINK C MSE B 58 N VAL B 59 1555 1555 1.33 LINK C ALA B 78 N MSE B 79 1555 1555 1.33 LINK C MSE B 79 N ALA B 80 1555 1555 1.34 LINK C ALA B 105 N MSE B 106 1555 1555 1.34 LINK C MSE B 106 N LYS B 107 1555 1555 1.33 LINK C GLU B 146 N MSE B 147 1555 1555 1.32 LINK C MSE B 147 N ILE B 148 1555 1555 1.33 CISPEP 1 HIS A 12 GLY A 13 0 -14.61 SITE 1 AC1 4 ARG A 32 HIS A 49 HIS A 77 ASP A 143 SITE 1 AC2 2 GLY A 173 ASN A 176 SITE 1 AC3 2 SER A 132 LYS A 137 SITE 1 AC4 4 GLN A 41 GLU A 158 LYS A 160 ARG A 163 SITE 1 AC5 3 CYS A 82 ILE A 83 GLY A 85 SITE 1 AC6 5 ARG B 32 HIS B 49 HIS B 77 ASP B 143 SITE 2 AC6 5 HOH B 410 SITE 1 AC7 4 ASP A 166 ASN B 39 LYS B 160 ARG B 163 SITE 1 AC8 5 GLN B 26 ARG B 29 VAL B 30 CYS B 82 SITE 2 AC8 5 ILE B 83 SITE 1 AC9 2 GLY B 173 ASN B 176 SITE 1 BC1 4 ALA A 90 ASN A 92 VAL B 36 VAL B 40 CRYST1 65.762 68.886 106.154 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015206 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009420 0.00000